Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

734
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
734
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

551
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
551
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

490
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
490
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

980
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
980

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Predictive Value of Impedance for Defibrillation Success After S-ICD Implantation: A Reliable Indicator?

JACC. Clinical electrophysiology·2026
Same author

Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT Trial.

Circulation·2026
Same author

Left atrial ablation using the dual-energy, lattice-tip catheter in the SAFE-Ablation Registry: How to avoid procedure-related stroke?

Heart rhythm·2026
Same author

Transhepatic Access (and Re-Access) for Electrophysiology Procedures in Adult Patients With Interrupted Inferior Vena Cava.

JACC. Clinical electrophysiology·2026
Same author

Transhepatic Access (and Re-Access) in Adult Patients With Interrupted Inferior Vena Cava Undergoing Electrophysiology Procedures.

JACC. Clinical electrophysiology·2026
Same author

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US.

Journal of the American College of Cardiology·2025

Related Experiment Video

Updated: Mar 7, 2026

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.5K

Hemodynamic Support for Ventricular Tachycardia Ablation.

Chandrasekar Palaniswamy1, Marc A Miller2, Vivek Y Reddy2

  • 1Division of Cardiology, Department of Medicine, University of California San Francisco Fresno Medical Education Program, 155 N Fresno Street, Fresno, CA 93701, USA.

Cardiac Electrophysiology Clinics
|February 8, 2017
PubMed
Summary

This review examines mechanical circulatory support devices for unstable ventricular tachycardia ablation. It analyzes device safety and efficacy, guiding patient selection and hemodynamic monitoring for improved outcomes.

Keywords:
Catheter ablationCerebral oximetryHemodynamic supportPercutaneous left ventricular assist deviceVentricular tachycardia

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.0K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Related Experiment Videos

Last Updated: Mar 7, 2026

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.5K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.0K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Critical Care Medicine

Background:

  • Unstable ventricular tachycardia (VT) poses significant risks during catheter ablation.
  • Mechanical circulatory support (MCS) devices offer potential hemodynamic stabilization.
  • Limited data exists on the safety and efficacy of MCS during VT ablation.

Purpose of the Study:

  • To review the role of MCS in catheter ablation for unstable VT.
  • To analyze the published clinical experience regarding MCS safety and efficacy during VT ablation.
  • To discuss patient selection, device characteristics, and hemodynamic monitoring for MCS-assisted VT ablation.

Main Methods:

  • Systematic review of published clinical studies.
  • Analysis of data on commercially available MCS devices: intra-aortic balloon pump, Impella, TandemHeart, and extracorporeal membrane oxygenation.
  • Discussion of patient selection criteria, device-specific considerations, and hemodynamic monitoring strategies.

Main Results:

  • MCS devices can provide hemodynamic support during VT ablation in unstable patients.
  • Published data suggests variable safety and efficacy profiles depending on the device and patient condition.
  • Successful VT ablation with MCS support has been reported, but complications can occur.

Conclusions:

  • Hemodynamic support with MCS devices is a viable option for select unstable VT patients undergoing ablation.
  • Careful patient selection, understanding device limitations, and meticulous hemodynamic monitoring are crucial for optimizing outcomes.
  • Further research is needed to establish standardized protocols and long-term efficacy of MCS in this setting.